Speaker Profile
Biography
Dr. Helen Y. Chu is Professor of Medicine and Epidemiology at the University of Washington. She studies respiratory viruses and vaccines, and has conducted clinical trials of vaccines and therapeutics, including maternal flu vaccine in Nepal, SARS-CoV-2 vaccines, and antivirals for treatment of COVID-19. As part of the Seattle Flu Study, she designed a prototype pandemic preparedness platform, conducting home-based testing for respiratory viruses with home delivery of antivirals. This study first identified COVID-19 community transmission in the US. Early in the pandemic, she established a cohort of individuals with SARS-CoV-2 to understand vaccine and infection-induced immunity, and factors that predict long COVID. She is a member of multiple NIH and CDC expert working groups on respiratory viruses and vaccines. For her work on the pandemic response, she received the 2021 Washingtonian of the Year award from the Governor of the State of Washington.
Session Abstract – PMWC 2025 Silicon Valley
Track Chairs:
Charles Chiu, UCSF
- PMWC 2025 Award Ceremony
Pioneer Honoree: Julie Louise Gerberding, FNIH
- Keynote: From Crisis to Cure: Navigating Public Health Challenges in the Era of Precision Diagnostics
- Julie Louise Gerberding, FNIH
- Harnessing Emerging Diagnostic Technologies in Primary and Critical Care (PANEL)
Chair: Mylynda Massart, UPMC
- Christopher Woods, Duke
- Helen Chu, U of Washington
- Yvonne Maldonado, Stanford
- Rose Lee, NIH - New Viral and Microbiome Associations with Cancer
Chair: Charles Chiu, UCSF
- Nancy Joseph, UCSF
- Melody Smith, Stanford
- Metagenomics and Partnerships: Monitoring Infectious Disease Threats
- Duncan MacCannell
- Adi V. Gundlapalli, CDC
- Mindy Nye, LabCorp - Innovative Therapeutics and Host-Pathogen Interactions in Infectious Disease Management (PANEL)
- Victor Nizet, UCSD
- Brad Spellberg, LA General Medical Center
- Nevan Krogan, UCSF
- Margaret Riley, University of Massachusetts